Apollo Endosurgery 

$10
2
+$0.07+0.76% Monday 20:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
416.34M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

1MayExpected
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2023
-0.28
-0.25
-0.22
-0.19
Expected EPS
-0.2167
Actual EPS
N/A

Financials

-51.84%Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
76.86MRevenue
-39.84MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow APEN. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Health Technology
Medical Specialties
Manufacturing
Biological Product (except Diagnostic) Manufacturing
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, as well as delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. Additionally, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Australia, Costa Rica, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.
Show more...
CEO
Gary Atkinson
Employees
202
Country
US
ISIN
US03767D1081
WKN
000A2DJ26

Listings

0 Comments

Share your thoughts

FAQ

What is Apollo Endosurgery stock price today?
The current price of APEN is $10 USD — it has increased by +0.76% in the past 24 hours. Watch Apollo Endosurgery stock price performance more closely on the chart.
What is Apollo Endosurgery stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Apollo Endosurgery stocks are traded under the ticker APEN.
What is Apollo Endosurgery market cap?
Today Apollo Endosurgery has the market capitalization of 416.34M
What is Apollo Endosurgery revenue for the last year?
Apollo Endosurgery revenue for the last year amounts to 76.86M USD.
What is Apollo Endosurgery net income for the last year?
APEN net income for the last year is -39.84M USD.
How many employees does Apollo Endosurgery have?
As of April 01, 2026, the company has 202 employees.
In which sector is Apollo Endosurgery located?
Apollo Endosurgery operates in the Manufacturing sector.
When did Apollo Endosurgery complete a stock split?
The last stock split for Apollo Endosurgery was on December 30, 2016 with a ratio of 1:5.5.
Where is Apollo Endosurgery headquartered?
Apollo Endosurgery is headquartered in San Diego, US.